Neurologic Events in Continuous-Flow Left Ventricular Assist Devices.

[1]  D. Morales,et al.  Mechanical circulatory support in children: past, present and future. , 2019, Translational pediatrics.

[2]  James W Long,et al.  Two‐Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure , 2018, The New England journal of medicine.

[3]  H. Iso,et al.  Relationship Between Bacteremia and Hemorrhagic Stroke in Patients With Continuous-Flow Left Ventricular Assist Device. , 2017, Circulation journal : official journal of the Japanese Circulation Society.

[4]  A. Jahangir,et al.  Trends, predictors and outcomes of ischemic stroke and intracranial hemorrhage in patients with a left ventricular assist device. , 2018, Annals of translational medicine.

[5]  Stefan Blankenberg,et al.  Gender differences and outcomes in left ventricular assist device support: The European Registry for Patients with Mechanical Circulatory Support. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  Robert L Kormos,et al.  Eighth annual INTERMACS report: Special focus on framing the impact of adverse events. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  C. Morgan,et al.  INTERMACS Analysis of Stroke During Support With Continuous-Flow Left Ventricular Assist Devices: Risk Factors and Outcomes. , 2017, JACC. Heart failure.

[8]  A. Nowacki,et al.  Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  M. Slaughter,et al.  The Treatment of Patients with Advanced Heart Failure Ineligible for Cardiac Transplantation with the HeartWare Ventricular Assist Device: Results of the ENDURANCE Supplement Trial , 2017 .

[10]  Nader Moazami,et al.  Stroke and Intracranial Hemorrhage in HeartMate II and HeartWare Left Ventricular Assist Devices: A Systematic Review , 2017, Neurocritical Care.

[11]  Gregory A. Ewald,et al.  A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure , 2017, The New England journal of medicine.

[12]  Valluvan Jeevanandam,et al.  Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure , 2017, The New England journal of medicine.

[13]  H. Kamel,et al.  Stroke Risk and Mortality in Patients With Ventricular Assist Devices , 2016, Stroke.

[14]  Koji Takeda,et al.  Outcomes after stroke complicating left ventricular assist device. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  Jan Claassen,et al.  Neuroendovascular Interventions for Acute Ischemic Strokes in Patients Supported with Left Ventricular Assist Devices: A Single-Center Case Series and Review of the Literature. , 2016, World neurosurgery.

[16]  J. Butler,et al.  Gender differences in the risk of stroke during support with continuous-flow left ventricular assist device. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  F. Pagani,et al.  Adverse neurologic events in patients bridged with long-term mechanical circulatory support: A device-specific comparative analysis. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  Robert L Kormos,et al.  Seventh INTERMACS annual report: 15,000 patients and counting. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  G. Ewald,et al.  The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies. , 2015, JACC. Heart failure.

[20]  Ranjit John,et al.  Stroke After Left Ventricular Assist Device Implantation: Outcomes in the Continuous-Flow Era. , 2015, The Annals of thoracic surgery.

[21]  G. Ewald,et al.  Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[22]  R. Lazar,et al.  Cerebrovascular disease in the era of left ventricular assist devices with continuous flow: risk factors, diagnosis, and treatment. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  M. Slaughter,et al.  Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support). , 2014, Journal of the American College of Cardiology.

[24]  A. Khaghani,et al.  Results of the post-market Registry to Evaluate the HeartWare Left Ventricular Assist System (ReVOLVE). , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[25]  J. Morgan,et al.  Stroke While on Long-Term Left Ventricular Assist Device Support: Incidence, Outcome, and Predictors , 2014, ASAIO journal.

[26]  A. Nair,et al.  Impact of Atrial Fibrillation in Patients With the HeartMate II Left Ventricular Assist Device , 2022 .

[27]  O. Howard Frazier,et al.  Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients. , 2014, Journal of the American College of Cardiology.

[28]  Nader Moazami,et al.  An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[29]  Chad E. Eckert,et al.  Blood pressure control in continuous flow left ventricular assist devices: efficacy and impact on adverse events. , 2014, The Annals of thoracic surgery.

[30]  F. Pagani,et al.  Preoperative atrial fibrillation increases risk of thromboembolic events after left ventricular assist device implantation. , 2013, The Annals of thoracic surgery.

[31]  Heather J Ross,et al.  Clinical Differences Between Continuous Flow Ventricular Assist Devices: A Comparison Between HeartMate II and HeartWare HVAD , 2013, Journal of cardiac surgery.

[32]  Igor Gregoric,et al.  HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[33]  Andres Ceballos,et al.  Computational fluid dynamics analysis of surgical adjustment of left ventricular assist device implantation to minimise stroke risk , 2013, Computer methods in biomechanics and biomedical engineering.

[34]  N. Smedira,et al.  Axial and centrifugal continuous-flow rotary pumps: a translation from pump mechanics to clinical practice. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[35]  G. Bhat,et al.  Are Blood Stream Infections Associated With an Increased Risk of Hemorrhagic Stroke in Patients With a Left Ventricular Assist Device? , 2012, ASAIO journal.

[36]  Pranav Loyalka,et al.  Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation , 2012, Circulation.

[37]  T. Ota,et al.  Asymmetric Pattern of Cerebrovascular Lesions in Patients After Left Ventricular Assist Device Implantation , 2012, Stroke.

[38]  Eiran Z. Gorodeski,et al.  Should Women Receive Left Ventricular Assist Device Support?: Findings From INTERMACS , 2012, Circulation. Heart failure.

[39]  G. Ewald,et al.  Outcomes in Advanced Heart Failure Patients With Left Ventricular Assist Devices for Destination Therapy , 2012, Circulation. Heart failure.

[40]  Khurram Shahzad,et al.  Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[41]  N. Smedira,et al.  Continuous flow left ventricular assist device outcomes in commercial use compared with the prior clinical trial. , 2011, The Annals of thoracic surgery.

[42]  Yoshifumi Naka,et al.  Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). , 2011, Journal of the American College of Cardiology.

[43]  O. Frazier,et al.  Comparison of outcomes in women versus men using a continuous-flow left ventricular assist device as a bridge to transplantation. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[44]  Martin Strueber,et al.  Multicenter evaluation of an intrapericardial left ventricular assist system. , 2011, Journal of the American College of Cardiology.

[45]  Nader Moazami,et al.  Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. , 2009, Journal of the American College of Cardiology.

[46]  O H Frazier,et al.  Use of a continuous-flow device in patients awaiting heart transplantation. , 2007, The New England journal of medicine.

[47]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.